A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers

Cancers- Switzerland

doi 10.3390/cancers11081158

Full Text

Abstract

Available in

Date

Authors

Publisher

MDPI AG

Related search

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction With Clinical Outcome

PLoS ONE
Multidisciplinary
2014English

A Two Kinase-Gene Signature Model Using CDK2 and PAK4 Expression Predicts Poor Outcome in Non-Small Cell Lung Cancers

Neoplasma
Cancer Research
2016English

Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer

Annals of Surgical Oncology
OncologySurgery
2015English

DNA Methyltransferase Expression in Triple-Negative Breast Cancer Predicts Sensitivity to Decitabine

Journal of Clinical Investigation
Medicine
2018English

Molecular Stratification of Triple-Negative Breast Cancers

Oncologist
Cancer ResearchMedicineOncology
2010English

Tight Junction Protein Junctional Adhesion Molecule-A Regulates the Expression of Receptor Tyrosine Kinase EPHA2 in Triple-Negative Breast Cancer Cells

Clinical Oncology and Research
2019English

22p * Development of a Brca1-Like Signature in Triple Negative Breast Cancers Within the Rather (Rational Therapy for Breast Cancer) Consortium

Annals of Oncology
MedicineOncologyHematology
2014English

BRCA1/2-negative Hereditary Triple-Negative Breast Cancers Exhibit BRCAness

International Journal of Cancer
Cancer ResearchOncology
2017English

A Prognostic Signature Based on Three-Genes Expression in Triple-Negative Breast Tumours With Residual Disease

npj Genomic Medicine
GeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy